Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 15, 2025, HUTCHMED (HCM) has a market cap of $2.46 billion USD. According to our data, HUTCHMED is ranked No.3658 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 15, 2025 | $2.46 B |
-0.18%
|
| Dec 31, 2024 | $2.46 B |
-20.43%
|
| Dec 29, 2023 | $3.10 B |
22.53%
|
| Dec 30, 2022 | $2.53 B |
-57.87%
|
| Dec 31, 2021 | $6.00 B |
9.56%
|
| Dec 31, 2020 | $5.47 B |
27.72%
|
| Dec 31, 2019 | $4.29 B |
8.58%
|
| Dec 31, 2018 | $3.95 B |
-41.43%
|
| Dec 29, 2017 | $6.74 B |
190.49%
|
| Dec 30, 2016 | $2.32 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 BeiGene
BGNE
|
$20.21 B |
-1.816 B
|
China
|
 Jiangsu Hengrui Medicine
600276.SS
|
$42.08 B |
-0.015 B
|
China
|
 Zai Lab
ZLAB
|
$3.33 B |
0.000 M
|
China
|
 Mindray
300760.SZ
|
$35.08 B |
-0.414 B
|
China
|
 Sino Biopharmaceutical
1177.HK
|
$8.21 B |
-0.369 B
|
China
|
| Market Cap | = | HCM Stock Price | * | HCM Shares Outstanding |
| = | $14.38 | * | 0.17 B | |
| = | $2.46 B |